Literature DB >> 30888585

Antiplatelet therapy for prevention of hemodialysis vascular access thrombosis and improving survival.

Matteo Tozzi1, Maurizio Gallieni2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30888585     DOI： 10.1007/s40620-019-00598-y

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   3.902


× No keyword cloud information.
  10 in total

1.  Role of antiplatelet therapy in the durability of hemodialysis access.

Authors:  Satinderjit Locham; Robert J Beaulieu; Hanaa Dakour-Aridi; Besma Nejim; Mahmoud B Malas
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

Review 2.  Antiplatelet agents in hemodialysis.

Authors:  Massimiliano Migliori; Vincenzo Cantaluppi; Alessia Scatena; Vincenzo Panichi
Journal:  J Nephrol       Date:  2016-12-08       Impact factor: 3.902

Review 3.  Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-15

Review 4.  Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.

Authors:  Nicola C Tanner; Anthony Da Silva
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

5.  Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease.

Authors:  Jingwen Tan; Sunjae Bae; Jodi B Segal; Junya Zhu; Dorry L Segev; G Caleb Alexander; Mara McAdams-DeMarco
Journal:  J Nephrol       Date:  2017-01-24       Impact factor: 3.902

6.  Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis.

Authors:  James S Kaufman; Theresa Z O'Connor; Jane Hongyuan Zhang; Robert E Cronin; Louis D Fiore; Michael B Ganz; David S Goldfarb; Peter N Peduzzi
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

7.  Effect of dipyridamole plus aspirin on hemodialysis graft patency.

Authors:  Bradley S Dixon; Gerald J Beck; Miguel A Vazquez; Arthur Greenberg; James A Delmez; Michael Allon; Laura M Dember; Jonathan Himmelfarb; Jennifer J Gassman; Tom Greene; Milena K Radeva; Ingemar J Davidson; T Alp Ikizler; Gregory L Braden; Andrew Z Fenves; James S Kaufman; James R Cotton; Kevin J Martin; James W McNeil; Asif Rahman; Jeffery H Lawson; James F Whiting; Bo Hu; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  N Engl J Med       Date:  2009-05-21       Impact factor: 91.245

8.  Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

Authors:  Laura M Dember; Gerald J Beck; Michael Allon; James A Delmez; Bradley S Dixon; Arthur Greenberg; Jonathan Himmelfarb; Miguel A Vazquez; Jennifer J Gassman; Tom Greene; Milena K Radeva; Gregory L Braden; T Alp Ikizler; Michael V Rocco; Ingemar J Davidson; James S Kaufman; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  JAMA       Date:  2008-05-14       Impact factor: 56.272

9.  Should patients be on antithrombotic medication for their first arteriovenous fistulae?

Authors:  Alexander Murley; Anika Wijewardane; Teun Wilmink; Jyoti Baharani
Journal:  J Vasc Access       Date:  2015-12-07       Impact factor: 2.283

10.  Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial.

Authors:  Mark A Crowther; Catherine M Clase; Peter J Margetts; Jim Julian; Kim Lambert; Denise Sneath; Ryuta Nagai; Sarah Wilson; Alistair J Ingram
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121
  10 in total
  1 in total

1.  Application Value and Relevance Analysis of the Risk Evaluation System for Arteriovenous Fistula Puncture in Thrombosis after Puncture.

Authors:  Mei Li; Chao Sun; Xuan Du
Journal:  J Healthc Eng       Date:  2021-12-02       Impact factor: 2.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.